Literature DB >> 8392089

Chrysotile asbestos upregulates gene expression and production of alpha-receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts.

J C Bonner1, A L Goodell, P G Coin, A R Brody.   

Abstract

PDGF isoforms have been postulated to serve as mediators of fibroblast proliferation and chemotaxis during lung fibrogenesis induced by asbestos inhalation. We have studied the interaction of chrysotile asbestos fibers with rat lung fibroblasts (RLF) in vitro and the consequent changes in PDGF receptor mRNA expression, PDGF binding, and mitogenic activity of PDGF isoforms. Northern blot analysis revealed that mRNA for the PDGF-receptor alpha subtype (PDGF-R alpha) on RLF was upregulated after a 24-h exposure to asbestos in culture (0.5-15 micrograms fibers/cm2). [125I]PDGF-BB receptor assays showed that normal RLF possess mainly PDGF-R beta and a paucity of PDGF-R alpha. In agreement with the Northern data, saturation binding of [125I]PDGF-BB to RLF exposed to asbestos demonstrated an approximately 40% increase in binding sites accompanied by a twofold decrease in receptor affinity. Treating asbestos-exposed RLF with PDGF-AA, which binds only PDGF-R alpha, blocked the PDGF binding sites that were upregulated by fiber exposure. PDGF-AA had increased mitogenic potency for fiber-exposed RLF, but PDGF-BB was a less potent mitogen for these RLF. Nonfibrogenic carbonyl iron spheres induced similar changes in PDGF growth responses. These data show that inorganic particulates alter the PDGF-R alpha population on RLF without significant change in PDGF-R beta.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392089      PMCID: PMC293628          DOI: 10.1172/JCI116584

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  A significant part of macrophage-derived growth factor consists of at least two forms of PDGF.

Authors:  K Shimokado; E W Raines; D K Madtes; T B Barrett; E P Benditt; R Ross
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

Review 2.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

3.  Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells.

Authors:  G R Grotendorst; T Chang; H E Seppä; H K Kleinman; G R Martin
Journal:  J Cell Physiol       Date:  1982-11       Impact factor: 6.384

4.  Cultured endothelial cells produce a platelet-derived growth factor-like protein.

Authors:  P E DiCorleto; D F Bowen-Pope
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

Review 5.  The pathogenesis of asbestos-associated diseases.

Authors:  J E Craighead; B T Mossman
Journal:  N Engl J Med       Date:  1982-06-17       Impact factor: 91.245

Review 6.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy.

Authors:  R G Crystal; J E Gadek; V J Ferrans; J D Fulmer; B R Line; G W Hunninghake
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

7.  Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells.

Authors:  C Schöllmann; R Grugel; D Tatje; J Hoppe; J Folkman; D Marmé; H A Weich
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

8.  Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos.

Authors:  L Y Chang; L H Overby; A R Brody; J D Crapo
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

9.  Interstitial accumulation of inhaled chrysotile asbestos fibers and consequent formation of microcalcifications.

Authors:  A R Brody; L H Hill
Journal:  Am J Pathol       Date:  1982-10       Impact factor: 4.307

10.  Platelet-derived growth factor in chemotactic for fibroblasts.

Authors:  H Seppä; G Grotendorst; S Seppä; E Schiffmann; G R Martin
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  8 in total

Review 1.  Role of platelet-derived growth factors in physiology and medicine.

Authors:  Johanna Andrae; Radiosa Gallini; Christer Betsholtz
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

2.  Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice.

Authors:  G Sakuntala Warshamana; Derek A Pociask; Krishna J Fisher; Jing-Yao Liu; Patricia J Sime; Arnold R Brody
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

3.  Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

Authors:  A B Rice; C R Moomaw; D L Morgan; J C Bonner
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 4.  Selected new developments in asbestos immunotoxicity.

Authors:  G J Rosenthal; E Corsini; P Simeonova
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

5.  Biologic effects induced in vitro by PM10 from three different zones of Mexico City.

Authors:  Ernesto Alfaro-Moreno; Leticia Martínez; Claudia García-Cuellar; James C Bonner; J Clifford Murray; Irma Rosas; Sergio Ponce de León Rosales; Alvaro R Osornio-Vargas
Journal:  Environ Health Perspect       Date:  2002-07       Impact factor: 9.031

Review 6.  The role of PDGF in radiation oncology.

Authors:  Minglun Li; Verena Jendrossek; Claus Belka
Journal:  Radiat Oncol       Date:  2007-01-11       Impact factor: 3.481

Review 7.  Analyzing the genes and peptide growth factors expressed in lung cells in vivo consequent to asbestos exposure and in vitro.

Authors:  A R Brody; J Y Liu; D Brass; M Corti
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 8.  Interstitial fibrosis and growth factors.

Authors:  J A Lasky; A R Brody
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.